Cerebral malaria is associated with low levels of circulating endothelial progenitor cells in african children

American Journal of Tropical Medicine and Hygiene

Volumn 80, Issue 4, 2009, Pages 541-546

  Gyan, Ben ^a   Goka, Bamenla Quarm ^b   Adjei, George O ^b   Tetteh, John K A ^a   Kusi, Kwadwo Asamoah ^a   Aikins, Anastasia ^a   Dodoo, Daniel ^a   Lesser, Martin L ^c   Sison, Cristina P ^c   Das, Sanchita ^d   Howard, Marion E ^d   Milbank, Elizabeth ^d   Fischer, Kimberly ^d   Rafii, Shahin ^d   Jin, David ^d   Golightly, Linnie M ^d  

^a University of Ghana   (Ghana)

^b UNIVERSITY OF GHANA   (Ghana)

^c FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH   (United States)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIBODY; STROMAL CELL DERIVED FACTOR 1; VASCULOTROPIN RECEPTOR 2; CD34 ANTIGEN; CHEMOKINE; GLYCOPROTEIN; LEUKOCYTE ANTIGEN; PEPTIDE;

ARTICLE; BRAIN BLOOD VESSEL; BRAIN MALARIA; CELL MIGRATION; CHILD; ENDOTHELIUM CELL; GHANA; HUMAN; MAJOR CLINICAL STUDY; MALE; NEGRO; PATHOPHYSIOLOGY; STEM CELL; CHEMISTRY; CYTOLOGY; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; INFANT; MALARIA; METABOLISM; PATHOLOGY; PRESCHOOL CHILD;

ANTIGENS, CD; ANTIGENS, CD34; CHEMOKINES; CHILD; CHILD, PRESCHOOL; ENDOTHELIAL CELLS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GHANA; GLYCOPROTEINS; HUMANS; INFANT; MALARIA, CEREBRAL; MALE; PEPTIDES; STEM CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 65349087257     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2009.80.541     Document Type: Article

References (42)

1. Turner G, 1997. Cerebral malaria. Brain Pathol 7:569-582.
2. Newton CR, Taylor TE, Whitten RO, 1998. Pathophysiology of fatal falciparum malaria in African children. Am J Trop Med Hyg 58:673-683.
3. Pongponratn E, Turner GD, Day NP, Phu NH, Simpson JA, Stepniewska K, Mai NT, Viriyavejakul P, Looareesuwan S, Hien TT, Ferguson DJ, White NJ, 2003. An ultrastructural study of the brain in fatal Plasmodium falciparum malaria. Am J Trop Med Hyg 69:345-359.
4. MacPherson GG,Warrell MJ, White NJ, Looareesuwan S,Warrell DA, 1985. Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol 119:385-401.
5. Taylor TE, Fu WJ, Carr RA, Whitten RO, Mueller JS, Fosiko NG, Lewallen S, Liomba NG, Molyneux ME, 2004. Differentiating the pathologies of cerebral malaria by postmortem parasite counts. Nat Med 10:143-145.
6. Adams S, Brown H, Turner G, 2002. Breaking down the bloodbrain barrier: signaling a path to cerebral malaria? Trends Parasitol 18: 360-366.
7. Brown H, Hien TT, Day N, Mai NT, Chuong LV, Chau TT, Loc PP, Phu NH, Bethell D, Farrar J, Gatter K, White N, Turner G, 1999. Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol 25: 331-340.
8. Combes V, Taylor TE, Juhan-Vague I, Mege JL, Mwenechanya J, Tembo M, Grau GE, Molyneux ME, 2004. Circulating endothelial microparticles in Malawian children with severe falciparum malaria complicated with coma. JAMA 291:2542-2544.
9. Muanza K,Traore B, Gay F, Krudsood S, Danis M, Looareesuwan S, 1999. Circulating receptors implicated in the cyto-adherence occurring in severe Plasmodium falciparum malaria in Thailand. Ann Trop Med Parasitol 93:449-455.
10. Turner GD, Ly VC, Nguyen TH, Tran TH, Nguyen HP, Bethell D, Wyllie S, Louwrier K, Fox SB, Gatter KC, Day NP, White NJ, Berendt AR, 1998. Systemic endothelial activation occurs in both mild and severe malaria. Correlating dermal microvascular endothelial cell phenotype and soluble cell adhesion molecules with disease severity. Am J Pathol 152: 1477-1487.
11. Horstmann RD, Dietrich M, 1985. Haemostatic alterations in malaria correlate to parasitaemia. Blut 51:329-335.
12. Mohanty D, Ghosh K, Nandwani SK, Shetty S, Phillips C, Rizvi S, Parmar BD, 1997. Fibrinolysis, inhibitors of blood coagulation, and monocyte derived coagulant activity in acute malaria. Am J Hematol 54:23-29.
13. de Mast Q, Groot E, Lenting PJ, de Groot PG, McCall M, Sauerwein RW, Fijnheer R, van der Ven A, 2007. Thrombocytopenia and release of activated von Willebrand Factor during early Plasmodium falciparum malaria.J Infect Dis 196:622-628.
14. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM, 1997. Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964-967.
15. Urbich C, Dimmeler S, 2004. Endothelial progenitor cells: characterization and role in vascular biology. Circ Res 95:343-353.
16. Lin Y, Weisdorf DJ, Solovey A, Hebbel RP, 2000. Origins of circulating endothelial cells and endothelial outgrowth from blood. J Clin Invest 105:71-77.
17. Rafii S, 2000. Circulating endothelial precursors: mystery, reality, and promise. J Clin Invest 105:17-19.
18. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA, Finkel T, 2003. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 348:593-600.
19. Hristov M, Erl W, Weber PC, 2003. Endothelial progenitor cells: mobilization, differentiation, and homing. Arterioscler Thromb Vasc Biol 23:1185-1189.
20. Mutunga M, Fulton B, Bullock R, Batchelor A, Gascoigne A, Gillespie JI, Baudouin SV, 2001. Circulating endothelial cells in patients with septic shock. Am J Respir Crit Care Med 163: 195-200.
21. Rosenzweig A, 2003. Endothelial progenitor cells. N Engl J Med 348:581-582.
22. Solovey A, Lin Y, Browne P, Choong S, Wayner E, Hebbel RP, 1997. Circulating activated endothelial cells in sickle cell anemia. N Engl J Med 337:1584-1590.
23. Sowemimo-Coker SO, Meiselman HJ, Francis RB Jr, 1989. Increased circulating endothelial cells in sickle cell crisis. Am J Hematol 31:263-265.
24. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M, Magner M, Isner JM, Asahara T, 1999. Ischemia-and cytokine- induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 5:434-438.
25. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S, 2001. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 89: E1-E7.
26. Woywodt A, Streiber F, de Groot K, Regelsberger H, Haller H, Haubitz M, 2003. Circulating endothelial cells as markers for ANCA-associated small-vessel vasculitis. Lancet 361:206-210.
27. Heeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, Martin H, Zeiher AM, Dimmeler S, 2004. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation 109:1615-1622.
28. Schmidt-Lucke C, Rossig L, Fichtlscherer S, Vasa M, Britten M, Kamper U, Dimmeler S, Zeiher AM, 2005. Reduced number of circulating endothelial progenitor cells predicts future cardiovascular events: proof of concept for the clinical importance of endogenous vascular repair. Circulation 111: 2981-2987.
29. Werner N, Kosiol S, Schiegl T, Ahlers P, Walenta K, Link A, Bohm M, Nickenig G, 2005. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 353:999-1007.
30. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M, Oz MC, Hicklin DJ, Witte L, Moore MA, Rafii S, 2000. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952-958.
31. Salven P, Mustjoki S, Alitalo R, Alitalo K, Rafii S, 2003.VEGFR-3 and CD133 identify a population of CD34+ lymphatic/vascular endothelial precursor cells. Blood 101:168-172.
32. WHO, 1990. Severe and complicated malaria. World Health Organization, Division of Control of Tropical Diseases. Trans R Soc Trop Med Hyg 84 (Suppl2): 1-65.
33. Vasa M, Fichtlscherer S, Adler K,Aicher A, Martin H, Zeiher AM, Dimmeler S, 2001. Increase in circulating endothelial progenitor cells by statin therapy in patients with stable coronary artery disease. Circulation 103:2885-2890.
34. Kurtzhals JA, Rodrigues O, Addae M, Commey JO, Nkrumah FK, Hviid L, 1997. Reversible suppression of bone marrow response to erythropoietin in Plasmodium falciparum malaria. Br J Haematol 97:169-174.
35. Yamaguchi J, Kusano KF, Masuo O, Kawamoto A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner JM, Asahara T, 2003. Stromal cell-derived factor-1 effects on ex vivo expanded endothelial progenitor cell recruitment for ischemic neovascularization. Circulation 107:1322-1328.
36. Shao H,Tan Y, Eton D, Yang Z, Uberti MG, Li S, Schulick A, Yu H, 2008. Statin and stromal cell-derived factor-1 additively promote angiogenesis by enhancement of progenitor cells incorporation into new vessels. Stem Cells 26:1376-1384.
37. Kopp HG, Ramos CA, Rafii S, 2006. Contribution of endothelial progenitors and proangiogenic hematopoietic cells to vascularization of tumor and ischemic tissue. Curr Opin Hematol 13: 175-181.
38. Marsh K, Snow RW, 1997. Host-parasite interaction and morbidity in malaria endemic areas. Philos Trans R Soc Lond B Biol Sci 352:1385-1394.
39. Greenwood B, Marsh K, Snow R, 1991. Why do some African children develop severe malaria? Parasitol Today 7:277-281.
40. Khakoo AY, Finkel T, 2005. Endothelial progenitor cells. Annu Rev Med 56:79-101.
41. Werner N, Nickenig G, 2006. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy? Arterioscler Thromb Vasc Biol 26:257-266.
42. Roncalli JG, Tongers J, Renault MA, Losordo DW, 2008. Endothelial progenitor cells in regenerative medicine and cancer: a decade of research. Trends Biotechnol 26:276-283.